These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12811108)

  • 1. Getting the cat back in the bag: reforming the way provinces manage drug expenditures to make them manageable.
    Levy AR; Gagnon YM
    Healthc Pap; 2002; 3(1):32-7; discussion 87-94. PubMed ID: 12811108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing healthcare costs within an integrated framework.
    Fernandes R
    Healthc Pap; 2002; 3(1):70-6; discussion 87-94. PubMed ID: 12811114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More of the same is not enough.
    Willison DJ
    Healthc Pap; 2002; 3(1):47-55; discussion 87-94. PubMed ID: 12811111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inter-provincial variation in government drug formularies.
    Grégoire JP; MacNeil P; Skilton K; Moisan J; Menon D; Jacobs P; McKenzie E; Ferguson B
    Can J Public Health; 2001; 92(4):307-12. PubMed ID: 11962119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Our advice? Get a budget!
    Brougham M; Metcalfe S; McNee W
    Healthc Pap; 2002; 3(1):83-5; discussion 87-94. PubMed ID: 12811116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Let evidence be the arbiter.
    Lindberg MC
    Healthc Pap; 2002; 3(1):43-6; discussion 87-94. PubMed ID: 12811110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug policy: making effective drugs available without bankrupting the healthcare system.
    Laupacis A; Anderson G; O'Brien B
    Healthc Pap; 2002; 3(1):12-30. PubMed ID: 12811107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug policy: the challenge is to overcome fragmentation.
    McFarlance A
    Healthc Pap; 2002; 3(1):38-42: discussion 87-94. PubMed ID: 12811109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from Europe on the funding of healthcare.
    Evans RG
    CHAC Rev; 1995; 23(3):9-11. PubMed ID: 10152517
    [No Abstract]   [Full Text] [Related]  

  • 10. Propaganda or the cost of innovation? Challenging the high price of new drugs.
    Ghinea N; Lipworth W; Kerridge I
    BMJ; 2016 Mar; 352():i1284. PubMed ID: 26968991
    [No Abstract]   [Full Text] [Related]  

  • 11. Moving beyond the drug budget silo mentality in Europe.
    Drummond M; Jönsson B
    Value Health; 2003; 6 Suppl 1():S74-7. PubMed ID: 12846928
    [No Abstract]   [Full Text] [Related]  

  • 12. Adoption of pharmaceutical innovation and the growth of drug expenditure in Taiwan: is it cost effective?
    Hsieh CR; Sloan FA
    Value Health; 2008; 11(2):334-44. PubMed ID: 18380646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care in Canada: a system in turmoil.
    Rathwell T
    Health Policy; 1994 Jan; 27(1):5-17. PubMed ID: 10133136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economics of prescription drug prices, government intervention, and the importation of drugs from Canada.
    Openshaw MS
    Nurs Econ; 2005; 23(6):307-11, 279. PubMed ID: 16459902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Look beyond budgets to the broader benefits.
    Dugal R; Mani A; Potvin K
    Healthc Pap; 2002; 3(1):77-82; discussion 87-94. PubMed ID: 12811115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in Prescription Drug Spending Leading Up to Health Reform.
    Blavin F; Waidmann T; Blumberg LJ; Roth J
    Med Care Res Rev; 2014 Aug; 71(4):416-32. PubMed ID: 24830379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug spending in Canada: recent trends and causes.
    Morgan S
    Med Care; 2004 Jul; 42(7):635-42. PubMed ID: 15213487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Federal/provincial financial arrangements: the poverty of economic advice.
    Kazanjian A; Hanvelt R
    Leadersh Health Serv; 1996; 5(3):15-9. PubMed ID: 10158404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Public Expenditures for Mental Health Services in Canadian Provinces: Dépenses publiques pour les services de santé mentale dans les provinces canadiennes.
    Wang J; Jacobs P; Ohinmaa A; Dezetter A; Lesage A
    Can J Psychiatry; 2018 Apr; 63(4):250-256. PubMed ID: 29228821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the future of Medicare in Canada.
    King RH
    Empl Benefits J; 1994 Mar; 19(1):17-20. PubMed ID: 10132232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.